Developing Transformative Therapies to Advance the Treatment of Gastrointestinal (GI) Disorders

Developing Transformative Therapies to Advance the Treatment of Gastrointestinal (GI) Disorders

Millions of patients in the US are living with serious, untreated, or inadequately controlled GI conditions - many of which can lead to other severe or potentially deadly health outcomes. It's time to change that!

Our Values

Succeed Together

Stay Nimble

Embrace “Why”

Follow the Science

Don’t Settle!

Our Focus

We are GI-focused company with products in development to treat serious conditions that affect millions of patients and that are untreated or not effectively treated today

Our Team

We have deep backgrounds in GI-focused drug development, clinical research, finance and commercialization with global and growth-stage companies

Advancing the Treatment of GI Disorders

Neurogastrx, Inc. is a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal disorders.